v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net income (loss) $ (1,864,873) $ 3,513,621
Adjustments to reconcile net income (loss) to cash provided by (used in) operating activities:    
Depreciation expense 15,570 8,512
Stock-based compensation expense 71,002 99,306
Non-cash loss on change in fair value of warrant liability 40,072
Amortization of discounts on marketable investment securities (58,209) (214,896)
Changes in operating assets and liabilities:    
Accrued interest income (58,580) (47,880)
Prepaid and other current assets 139,120 190,337
Accounts payable 88,543 (724,532)
Accrued expenses (301,830) (457,021)
Cash provided by (used in) operating activities (1,969,257) 2,407,519
Cash flows from investing activities:    
Purchases of marketable investment securities (5,082,073) (10,789,840)
Maturities of marketable investment securities 4,200,000 6,700,000
Cash used in investing activities (882,073) (4,089,840)
Cash flows from financing activities:    
Costs associated with ATM Offering (8,100)
Cash used in financing activities (8,100)
Net decrease in cash and cash equivalents (2,851,330) (1,690,421)
Cash and cash equivalents at beginning of period 6,205,926 4,771,758
Cash and cash equivalents at end of period 3,354,596 3,081,337
Supplemental disclosure of non-cash investing and financing activity:    
Net unrealized loss on available-for-sale securities $ (3,617) $ (17,863)